Sign in

CIK 0001818382

  • Non-accelerated filer
  • Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851763759
Phone
+1 919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
  1. 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 20,000 shares at $2.60 ($52,000)
  2. 4 Open-market buy President, CEO and Director bought 10,000 shares at $2.54 ($25,400)
  3. 4 Open-market buy Director bought 10,000 shares at $2.54 ($25,400)
  4. 4 Open-market sale President, CEO and Director sold 239,538 shares at $2.53 ($606,031)
  5. 4 Open-market sale Director sold 239,538 shares at $2.53 ($606,031)
  6. 4 Open-market sale 10% owner sold 239,538 shares at $2.53 ($606,031)
  7. 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $3.09 ($15,450)
  8. 4 Open-market sale President, CEO and Director sold 699,730 shares at an average $2.78 ($1,945,509)
  9. 4 Open-market sale Director sold 699,730 shares at an average $2.78 ($1,945,509)
  10. 4 Open-market sale 10% owner sold 699,730 shares at an average $2.78 ($1,945,509)
  11. 4 Exercise or conversion Chief Operating Officer acquired 6,564 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy President, CEO and Director bought 2,000 shares at $4.14 ($8,280)

Page 8 of 12 · 235 filings